Press Releases

2022-04-26
Regulatory

Our objective with Amp01 is to offer an enhanced customer experience through a significantly longer release profile of both nicotine and flavor, than what exists on the market today

2022-04-25
Regulatory

Amplicon will premiere two products at the Global Forum on Nicotine, which will be held in Warsaw on 16-18 June 2022. The world's largest annual conference in the tobacco and nicotine industry attracts a large number of visitors with experts, media, consumers, and industry professionals from many countries.

2022-04-06
Regulatory

The annual general meeting in Emplicure AB (publ) (the "Company") was held on Wednesday 6 April 2022 in the premises of United Spaces, Rådhuset Vaksalagatan 2, Uppsala.

2022-04-05
Regulatory

As part of broadening Emplicure's project and product development, an agreement has been signed with the Department of Materials Science at Uppsala University, Sweden.

The agreement includes advanced materials science characterization of drug formulations developed by Emplicure, as well as collaboration to develop new formulations of biological drugs (biologics).

2022-04-01
Regulatory

Emplicure AB (publ) today announces that a patent is set to be granted by the Australian Patent Office for inhalation of pharmaceuticals.

2022-03-30
Regulatory

Emplicure AB (publ) today announces that a patent is set to be granted by the Australian Patent Office for Amplicon's nicotine inhalation technology.

2022-03-17
Regulatory

Emplicure AB (publ) is set to be granted a patent by the Japan Patent Office for inhalation of pharmaceuticals.

2022-03-16
Regulatorisk

Emplicure AB:s (publ) årsredovisning för 2021 har offentliggjorts och finns tillgänglig på Emplicures webbplats www.emplicure.com

2022-03-10

Emplicure's CEO Torbjörn W. Larsson will present the company on two separate occasions in March, at Aktiespararna and BioStock.

2022-03-09
Regulatorisk

Detta är en rättelse av det PM - Kallelse till årsstämma i Emplicure AB (publ) som publicerades tidigare idag. Den tidigare kallelsen var felaktigt MAR-klassad.

1
2
3
4
5
6

GET STARTED

Do you want to know more?

Contact us today.